Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolmitriptan Nasal Spray for Acute Migraine in Adolescents
NCT01211145Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of zolmitriptan in migraine, sponsored by AstraZeneca. Started Sep 2010; status: completed.
02
Drugs
zolmitriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01211145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01211145.